Risky Business –
The Pharmaceutical Industry Boardgame

A highly stimulating programme on pharmaceutical R&D and BD&L in the form of a boardgame called Risky Business.
Read more…

Decision Analysis in Pharmaceutical R&D

Courses for R&D portfolio managers and R&D project leaders and teams to improve strategic decision making.
Read more…

Customised Progammes

We tailor existing courses on strategy and decision analysis or create new courses for specific training needs.
Read more…

An engaging course to experience the multi−year product development process in just half a day, and to sharpen strategic thinking at all levels of an organisation.

"We have now included the Risky Business Workshop format in different settings and for various occasions. Each time it has been a success with participants whether for communications, country managers or even for students and others not necessarily from within the pharmaceutical industry. The Catenion Academy has been able to take complex ideas and make them understandable and has tailored this information to the different levels of knowledge and interest of our audiences. Overall the group interaction is quite important, but for me it is the content of the interspersed topical presentations that really drives the ideas home and make the workshop complete. Catenion has also proved to be up to the task of managing both small and large events. I have been impressed by the response."

Dr. Lukas Pfister
Executive Director
Public Policy Europe and Canada
MSD (Europe) Inc.

Read more client testimonials...

The Catenion Academy is the education arm of the management consulting firm Catenion.

The Catenion Academy helps pharmaceutical professionals to reduce the risks involved in bringing new drugs to the market and to improve complex decision-making in R&D and BD&L. Our programmes are based on pharmaceutical industry strategy games, standard methods in decision analysis, and proprietary consulting approaches developed by Catenion – approaches that have helped to address and solve strategic issues for many of the world’s leading pharmaceutical companies.
Read more…